Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-26-023167
Filing Date
2026-03-04
Accepted
2026-03-04 07:21:32
Documents
75
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clrb-20251231x10k.htm   iXBRL 10-K 2323748
2 EX-23.1 clrb-20251231xex23d1.htm EX-23.1 2115
3 EX-31.1 clrb-20251231xex31d1.htm EX-31.1 11035
4 EX-31.2 clrb-20251231xex31d2.htm EX-31.2 11033
5 EX-32.1 clrb-20251231xex32d1.htm EX-32.1 9601
  Complete submission text file 0001104659-26-023167.txt   8870482

Data Files

Seq Description Document Type Size
6 EX-101.SCH clrb-20251231.xsd EX-101.SCH 52870
7 EX-101.CAL clrb-20251231_cal.xml EX-101.CAL 63401
8 EX-101.DEF clrb-20251231_def.xml EX-101.DEF 221417
9 EX-101.LAB clrb-20251231_lab.xml EX-101.LAB 449159
10 EX-101.PRE clrb-20251231_pre.xml EX-101.PRE 388882
78 EXTRACTED XBRL INSTANCE DOCUMENT clrb-20251231x10k_htm.xml XML 1436991
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36598 | Film No.: 26718844
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)